Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07025356 · ClinicalTrials.gov registry record
Observational Study of the the Use of a Trigeminal Vagal Nerve Stimulator in the Routine Care of Native Americans With Diabetic Neuropathy Pain. Pain Scores, Drug Use and Glucose Measurements Will be Assessed
A clinical trial of Diabetic Neuropathy With Neurologic Complication, sponsored by Vagus Nerve Society.
- Completed
- Registry status
- 83
- Enrollment target
- 1
- Study location
NCT07025356: Completed study of Diabetic Neuropathy With Neurologic Complication, sponsored by Vagus Nerve Society.
NCT07025356 is a study of Diabetic Neuropathy With Neurologic Complication that has completed, run by Vagus Nerve Society. The registered enrollment target is 83 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07025356, a study of Diabetic Neuropathy With Neurologic Complication, has completed, sponsored by Vagus Nerve Society.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy
Primary Outcome
Periodic pain scores will be measured for 90 days and possibly longer
Conditions Studied
Interventions
- DRUG Implantation of a trigeminal Vagus cervical nerve stimulator system
- DEVICE Implantation of a neurostimulator system for trigeminal vagal cervical nerve stimulation
Study Locations (1)
South Dakota
- Continuum of Care Clinic - Pine Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2022-09-23 |
| Est. Completion | 2025-06-01 |
What the finished NCT07025356 record still lists
NCT07025356 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 1 condition, with Diabetic Neuropathy With Neurologic Complication appearing as the primary indexed condition, and to 2 interventions - of which Implantation of a trigeminal Vagus cervical nerve stimulator system is the first listed.
NCT07025356 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT07025356 about?
NCT07025356 is a clinical study titled "Observational Study of the the Use of a Trigeminal Vagal Nerve Stimulator in the Routine Care of Native Americans With Diabetic Neuropathy Pain. Pain Scores, Drug Use and Glucose Measurements Will be Assessed". This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy
What is the current status of trial NCT07025356?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2022-09-23. Estimated completion is 2025-06-01.
What conditions does trial NCT07025356 study?
This clinical trial studies the following conditions: Diabetic Neuropathy With Neurologic Complication.
What interventions are being tested in trial NCT07025356?
The interventions under investigation include: Implantation of a trigeminal Vagus cervical nerve stimulator system (DRUG), Implantation of a neurostimulator system for trigeminal vagal cervical nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT07025356?
This trial is sponsored by Vagus Nerve Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07025356 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI